vs
アボット(ABT)とAveanna Healthcare Holdings, Inc.(AVAH)の財務データ比較。上の社名をクリックして会社を切り替えられます
アボットの直近四半期売上が大きい($11.5B vs $621.9M、Aveanna Healthcare Holdings, Inc.の約18.4倍)。アボットの純利益率が高く(15.5% vs 2.3%、差は13.2%)。Aveanna Healthcare Holdings, Inc.の前年同期比売上増加率が高い(22.2% vs 4.4%)。過去8四半期でAveanna Healthcare Holdings, Inc.の売上複合成長率が高い(14.0% vs 7.2%)
アボットは米国イリノイ州アボットパークに本社を置く多国籍医療ヘルスケア企業です。米国外向けの医薬品、診断製品、栄養製品、医療機器の開発・製造・販売を事業の柱とし、世界各国の人々の健康をサポートしています。
Aveanna Healthcare Holdings, Inc.は米国の代表的な在宅・地域密着型医療サービス事業者で、小児在宅看護、成人向け介護、ホスピス、輸液療法などを提供しています。全米に広がる地域ケアセンター網を通じ、公的・民間保険加入者を中心にサービスを提供しています。
ABT vs AVAH — 直接比較
損益計算書 — Q4 2025 vs Q3 2026
| 指標 | ||
|---|---|---|
| 売上 | $11.5B | $621.9M |
| 純利益 | $1.8B | $14.1M |
| 粗利率 | 57.0% | 32.6% |
| 営業利益率 | 19.6% | 8.6% |
| 純利益率 | 15.5% | 2.3% |
| 売上前年比 | 4.4% | 22.2% |
| 純利益前年比 | -80.8% | 132.8% |
| EPS(希薄化後) | $1.01 | $0.06 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $11.5B | — | ||
| Q3 25 | $11.4B | $621.9M | ||
| Q2 25 | $11.1B | $589.6M | ||
| Q1 25 | $10.4B | $559.2M | ||
| Q4 24 | $11.0B | $519.9M | ||
| Q3 24 | $10.6B | $509.0M | ||
| Q2 24 | $10.4B | $505.0M | ||
| Q1 24 | $10.0B | $490.7M |
| Q4 25 | $1.8B | — | ||
| Q3 25 | $1.6B | $14.1M | ||
| Q2 25 | $1.8B | $27.0M | ||
| Q1 25 | $1.3B | $5.2M | ||
| Q4 24 | $9.2B | $29.2M | ||
| Q3 24 | $1.6B | $-42.8M | ||
| Q2 24 | $1.3B | $13.9M | ||
| Q1 24 | $1.2B | $-11.2M |
| Q4 25 | 57.0% | — | ||
| Q3 25 | 55.4% | 32.6% | ||
| Q2 25 | 56.4% | 35.8% | ||
| Q1 25 | 56.9% | 32.8% | ||
| Q4 24 | 55.0% | 33.0% | ||
| Q3 24 | 55.8% | 31.4% | ||
| Q2 24 | 55.6% | 31.3% | ||
| Q1 24 | 55.2% | 29.7% |
| Q4 25 | 19.6% | — | ||
| Q3 25 | 18.1% | 8.6% | ||
| Q2 25 | 18.4% | 13.6% | ||
| Q1 25 | 16.3% | 9.3% | ||
| Q4 24 | 17.4% | 8.8% | ||
| Q3 24 | 17.5% | 6.7% | ||
| Q2 24 | 16.1% | 7.4% | ||
| Q1 24 | 13.9% | 4.7% |
| Q4 25 | 15.5% | — | ||
| Q3 25 | 14.5% | 2.3% | ||
| Q2 25 | 16.0% | 4.6% | ||
| Q1 25 | 12.8% | 0.9% | ||
| Q4 24 | 84.1% | 5.6% | ||
| Q3 24 | 15.5% | -8.4% | ||
| Q2 24 | 12.5% | 2.8% | ||
| Q1 24 | 12.3% | -2.3% |
| Q4 25 | $1.01 | — | ||
| Q3 25 | $0.94 | $0.06 | ||
| Q2 25 | $1.01 | $0.13 | ||
| Q1 25 | $0.76 | $0.03 | ||
| Q4 24 | $5.26 | $0.15 | ||
| Q3 24 | $0.94 | $-0.22 | ||
| Q2 24 | $0.74 | $0.07 | ||
| Q1 24 | $0.70 | $-0.06 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | ||
|---|---|---|
| 現金・短期投資手元流動性 | $8.9B | $145.9M |
| 総負債低いほど良い | $12.9B | $1.3B |
| 株主資本純資産 | $52.1B | $9.2M |
| 総資産 | $86.7B | $1.8B |
| 負債/資本比率低いほどレバレッジが低い | 0.25× | 141.83× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $8.9B | — | ||
| Q3 25 | $7.7B | $145.9M | ||
| Q2 25 | $7.3B | $100.7M | ||
| Q1 25 | $6.8B | $71.5M | ||
| Q4 24 | $8.0B | $84.3M | ||
| Q3 24 | $7.8B | $78.5M | ||
| Q2 24 | $7.2B | $47.7M | ||
| Q1 24 | $6.7B | $42.6M |
| Q4 25 | $12.9B | — | ||
| Q3 25 | — | $1.3B | ||
| Q2 25 | — | $1.3B | ||
| Q1 25 | — | $1.3B | ||
| Q4 24 | $14.1B | $1.3B | ||
| Q3 24 | — | $1.3B | ||
| Q2 24 | — | $1.3B | ||
| Q1 24 | — | $1.3B |
| Q4 25 | $52.1B | — | ||
| Q3 25 | $51.0B | $9.2M | ||
| Q2 25 | $50.6B | $-12.0M | ||
| Q1 25 | $48.8B | $-100.1M | ||
| Q4 24 | $47.7B | $-123.6M | ||
| Q3 24 | $39.8B | $-156.4M | ||
| Q2 24 | $39.3B | $-119.0M | ||
| Q1 24 | $38.8B | $-136.3M |
| Q4 25 | $86.7B | — | ||
| Q3 25 | $84.2B | $1.8B | ||
| Q2 25 | $84.0B | $1.8B | ||
| Q1 25 | $81.4B | $1.7B | ||
| Q4 24 | $81.4B | $1.7B | ||
| Q3 24 | $74.4B | $1.6B | ||
| Q2 24 | $73.0B | $1.7B | ||
| Q1 24 | $72.5B | $1.6B |
| Q4 25 | 0.25× | — | ||
| Q3 25 | — | 141.83× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.30× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | ||
|---|---|---|
| 営業キャッシュフロー直近四半期 | $3.3B | $33.2M |
| フリーキャッシュフロー営業CF - 設備投資 | $2.6B | — |
| FCFマージンFCF / 売上 | 22.9% | — |
| 設備投資強度設備投資 / 売上 | 6.0% | — |
| キャッシュ転換率営業CF / 純利益 | 1.87× | 2.36× |
| 直近12ヶ月FCF直近4四半期 | $7.4B | — |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $3.3B | — | ||
| Q3 25 | $2.8B | $33.2M | ||
| Q2 25 | $2.0B | $51.6M | ||
| Q1 25 | $1.4B | $-8.6M | ||
| Q4 24 | $2.9B | $13.4M | ||
| Q3 24 | $2.7B | $29.4M | ||
| Q2 24 | $2.0B | $1.8M | ||
| Q1 24 | $1.0B | $-12.0M |
| Q4 25 | $2.6B | — | ||
| Q3 25 | $2.3B | — | ||
| Q2 25 | $1.5B | — | ||
| Q1 25 | $933.0M | — | ||
| Q4 24 | $2.1B | — | ||
| Q3 24 | $2.1B | — | ||
| Q2 24 | $1.4B | — | ||
| Q1 24 | $627.0M | — |
| Q4 25 | 22.9% | — | ||
| Q3 25 | 20.2% | — | ||
| Q2 25 | 13.9% | — | ||
| Q1 25 | 9.0% | — | ||
| Q4 24 | 19.6% | — | ||
| Q3 24 | 20.2% | — | ||
| Q2 24 | 13.8% | — | ||
| Q1 24 | 6.3% | — |
| Q4 25 | 6.0% | — | ||
| Q3 25 | 4.4% | — | ||
| Q2 25 | 4.5% | — | ||
| Q1 25 | 4.7% | — | ||
| Q4 24 | 6.6% | — | ||
| Q3 24 | 5.2% | — | ||
| Q2 24 | 5.1% | — | ||
| Q1 24 | 4.0% | — |
| Q4 25 | 1.87× | — | ||
| Q3 25 | 1.70× | 2.36× | ||
| Q2 25 | 1.15× | 1.91× | ||
| Q1 25 | 1.07× | -1.66× | ||
| Q4 24 | 0.31× | 0.46× | ||
| Q3 24 | 1.64× | — | ||
| Q2 24 | 1.51× | 0.13× | ||
| Q1 24 | 0.84× | — |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
ABT
セグメントデータなし
AVAH
| Private Duty Services | $514.4M | 83% |
| Home Health And Hospice | $62.4M | 10% |
| Medical Solutions | $45.1M | 7% |